Janux Therapeutics goes public
Janux Therapeutics, a biopharmaceutical company, has raised $193.8 million for its IPO after pricing its 11.4 million shares at $17 per share.
11 June 2021•2 mins read
Janux Therapeutics, a biopharmaceutical company, has raised $193.8 million for its IPO after pricing its 11.4 million shares at $17 per share.
Branford Castle acquires plant-nutrition firm Floratine as Fund III debut
7 hours ago · 2 mins read
Carlyle agrees sale of Disguise to Yamaha after more than tripling revenue
7 hours ago · 2 mins read
PE backs hematology care and diagnostics: 5 deals
10 hours ago · 2 mins read
Arcline agrees Akron Bio sale to MaxCyte in $152m deal
12 November 2026 · 2 mins read
Nordic Capital-backed Inovalon agrees deal to buy prescription tech firm DrFirst
12 November 2026 · 2 mins read
Trinity Hunt’s Allvia adds Humani HR in first Canadian expansion
12 November 2026 · 1 min read
Aquiline backs Beni Solutions, provider of affordable small-business health plans
12 November 2026 · 1 min read
